-
Pfizer and AZ topped the list, and Baekje entered the top 10
Time of Update: 2022-06-02
On April 22, IDEA Pharma released the global pharmaceutical innovation and invention index list, Pfizer and AZ ranked first in the two lists respectively; BeiGene and Takeda became the two companies that rose the most; BioNTech, UCB, Horizon, Shionogi is this year's newcomer .
-
Courier molecular glue cutting-edge once again reached a research and development cooperation, pointing to neurological diseases
Time of Update: 2022-05-30
▎WuXi AppTec Content Team Editor Today, Plexium announced that it has entered into a research and development agreement with AbbVie to jointly develop innovative targeted protein degradation therapies for neurological diseases .
-
Outbreaks and etiology of unexplained childhood hepatitis in the UK and other places
Time of Update: 2022-05-29
Written | Comments by Xie Youhua, Chen Jieliang, Wang Yongxiang, Yuan Zhenghong | Zhang Wenhong Source | "Microbes and Infections" On March 31, 2022, Scotland first reported five cases of children with severe hepatitis of unknown cause .
-
The National Health and Medical Commission issued a document: 13,000 private hospitals will be inspected
Time of Update: 2022-05-13
Inspection focus: from qualification to epidemic prevention and control According to the documents released by the National Health and Health Commission, the inspection content includes four aspects: institutional setup, standardized practice, operation management, and epidemic prevention and control, covering 15 items including hospital naming, personnel qualifications, and normalized epidemic prevention and control measures .
-
IQVIA Releases: Review of China's Retail Pharmacy Market in 2021
Time of Update: 2022-04-28
Local companies still occupy a larger share of the retail market, accounting for 74% of the national retail pharmacy market sales, with a growth rate of 0.
In the retail prescription drug market, local companies account for 62% of the market share, driving the market growth with a growth rate of 2.
-
Clariant strengthens research and development capabilities of Toyama base
Time of Update: 2021-12-28
In addition to being the global center for Clariant's nickel-based hydrogenation and styrene catalyst research and development, the Toyama site also involves other research fields, including customized catalysts, emission control, and the technical application of new energy conversion chemicals .
-
J Hematol Oncol: Incidence and mortality of 29 cancers worldwide in the past 30 years
Time of Update: 2021-12-04
Global, regional, and national cancer incidence and death for 29 cancer groups in 2019 and trends analysis of the global cancer burden, 1990-2019 .
1186/s13045-021-01213-zGlobal, regional, and national cancer incidence and death for 29 cancer groups in 2019 and trends analysis of the global cancer burden, 1990-2019 in this message
-
Under the trend of innovation, the pharmaceutical industry has set off a wave of cooperation
Time of Update: 2021-11-15
On October 22, Genetron Health, which focuses on providing tumor molecular detection, cancer early screening and companion diagnostic development services, announced that it has entered into an agreement with Jiangsu Fosun Pharmaceutical Sales Co.
-
Message from Zhong Nanshan on Medical Education: Focus on Cultivating the Spirit of Innovation
Time of Update: 2021-11-11
He hoped that the education of the medical school should be "health-centered" instead of "treatment-centered", so as to achieve early detection, early diagnosis and early treatment of chronic diseases .
-
Express significantly slows down the disease progression of breast cancer patients, and the phase 3 results of oral estrogen receptor degrading agents are positive
Time of Update: 2021-11-04
▎Editor of WuXi AppTec Content Team On October 20, 2021, Menarini Group and Radius Health announced that selective estrogen receptor degradant (SERD) elacestrant has obtained positive results in a phase 3 clinical trial .
-
JAMA: Emojis allow patients and doctors to communicate better
Time of Update: 2021-09-20
Doctors at Massachusetts General Hospital believe that emoji (Emoji) is becoming a valuable tool in the medical field, allowing patients to better express symptoms, concerns, and other clinically relevant information .
-
WHO: A total of 213,050,725 confirmed cases of new crowns worldwide
Time of Update: 2021-09-03
WHO: The global cumulative number of confirmed cases of new crown reached 213,050,725 WHO: The global cumulative number of confirmed cases of new crown reached 213,050,725 WHO: The
-
WHO: Prioritize vaccinations for the most vulnerable
Time of Update: 2021-08-26
The chief scientist of the WHO Sumia Swaminathan said that if all high-income countries decide to vaccinate their population over the age of 50 with a booster shot, Then nearly 1 billion doses of vaccine will be needed .
-
Nearly 500,000 people confirmed that cooking with coal or wood is at increased risk of eye diseases such as cataracts
Time of Update: 2021-08-15
Recently, a large-scale study of nearly 500,000 people in China published in the journal PLOS Med revealed that long-term use of “dirty” solid fuels (coal or wood) for cooking will not only increase the risk of conjunctival diseases, but also increase cataracts and cataracts.
-
Due to the unfair distribution of vaccines, global herd immunity is still out of reach-99% of people in poor countries are not vaccinated
Time of Update: 2021-07-28
Distribution is distributionMany wealthy countries have adopted the strategy of over-purchasing the dose of the new crown vaccine in advance .
Even COVAX's goal-to allow low-income countries to "receive enough doses to vaccinate up to 20% of their population"-cannot control the spread of the new crown in these places .
